GlaxoSmithKline reported 6.33B in Stock for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Almirall ALM:SM 130.92M 1.48M
Amgen AMGN:US $ 4115M 98M
Argen X Bv ARGX:BB 59.22M 38.68M
Bayer BAYN:GR € 10125M 332M
Biogen BIIB:US $ 1254.8M 83M
Bristol Myers Squibb BMY:US $ 2137M 184M
Eli Lilly And LLY:US $ 3824.9M 164.1M
Fresenius FRE:GR € 4197M 105M
Gilead Sciences GILD:US $ 2988M 8M
GlaxoSmithKline GSK:LN 6330M 114M
GRIFOLS GRF:SM € 2124.39M 13.61M
H. Lundbeck A/S LUN:DC 2.6B 14M
Hikma Pharmaceutical HIK:LN 736M 21M
Merck MRK:GR € 3564M 102M
Novartis NOVN:VX SF 7111M 114M
Orion ORNBV:FH € 272.8M 17.4M
Recordati REC:IM € 257M 13.32M
Regeneron Pharmaceuticals REGN:US $ 1983.9M 318.6M